HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1ra) INCREASES SURVIVAL TIME IN PATIENTS WITH SEPSIS SYNDROME AND END ORGAN DYSFUNCTION (EOD)

1994 ◽  
Vol 22 (1) ◽  
pp. A193 ◽  
Author(s):  
John Pribble ◽  
Charles Fisher ◽  
Steven Opal ◽  
Robert Balk ◽  
Gus Slotman ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Survival Time ◽  
Organ Dysfunction ◽  
Interleukin 1 ◽  
Sepsis Syndrome ◽  
Interleukin 1 Receptor Antagonist

THE IMPACT OF INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1ra) ON THE HOSPITAL AND ICU LENGTH OF STAY OF PATIENTS WITH SEPSIS SYNDROME

1994 ◽  
Vol 22 (1) ◽  
pp. A117
Author(s):  
Leslie Noe ◽  
John Pribble ◽  
Steven Barriere ◽  
Charles Fisher ◽  
Jean-Francois Dhainaut ◽  
...  
Keyword(s):  
Length Of Stay ◽  
Receptor Antagonist ◽  
Interleukin 1 ◽  
Sepsis Syndrome ◽  
Interleukin 1 Receptor Antagonist ◽  
Icu Length Of Stay ◽  
The Impact

Elevated interleukin-1 receptor antagonist levels in pediatric sepsis syndrome

1997 ◽  
Vol 131 (4) ◽  
pp. 587-591 ◽  
Author(s):  
Lindy M. Samson ◽  
Upton D. Allen ◽  
W.David Creery ◽  
Francisco Diaz-Mitoma ◽  
Ram N. Singh
Keyword(s):  
Receptor Antagonist ◽  
Interleukin 1 ◽  
Sepsis Syndrome ◽  
Interleukin 1 Receptor Antagonist ◽  
Pediatric Sepsis
Sign in / Sign up

Export Citation Format

Share Document